Autolus Therapeutics PLC (AUTL) is around the bottom of the Biotechnology industry according to InvestorsObserver. AUTL received an overall rating of 34, which means that it scores higher than 34 percent of all stocks. Autolus Therapeutics PLC also achieved a score of 23 in the Biotechnology industry, putting it above 23 percent of Biotechnology stocks. Biotechnology is ranked 16 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Autolus Therapeutics PLC Stock Today?
Autolus Therapeutics PLC (AUTL) stock is trading at $7.60 as of 11:19 AM on Friday, Feb 12, an increase of $0.46, or 6.5% from the previous closing price of $7.14. The stock has traded between $7.04 and $7.70 so far today. Volume today is high. So far 1,529,581 shares have traded compared to average volume of 657,454 shares.
Click Here to get the full Stock Score Report on Autolus Therapeutics PLC (AUTL) Stock.
